Zhejiang Hisun Pharmaceutical Co Ltd Asset Resilience Ratio
Zhejiang Hisun Pharmaceutical Co Ltd asset resilience ratio. Zhejiang Hisun Pharmaceutical Co Ltd (600267) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang Hisun Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Hisun Pharmaceutical Co Ltd (2000–2025)
Asset resilience ratio of Zhejiang Hisun Pharmaceutical Co Ltd from 2000 to 2025. This chart shows how Zhejiang Hisun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 600267 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Hisun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Zhejiang Hisun Pharmaceutical Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.99 Million | 0.01% |
| Total Liquid Assets | CN¥1.99 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Hisun Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Hisun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Hisun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Zhejiang Hisun Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2000–2025)
Zhejiang Hisun Pharmaceutical Co Ltd asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for Zhejiang Hisun Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.02% | CN¥2.37 Million ≈ $346.83K |
CN¥15.05 Billion ≈ $2.20 Billion |
+0.01pp |
| 2023-12-31 | 0.00% | CN¥292.62K ≈ $42.82K |
CN¥17.61 Billion ≈ $2.58 Billion |
-0.01pp |
| 2021-12-31 | 0.02% | CN¥3.05 Million ≈ $446.70K |
CN¥19.37 Billion ≈ $2.84 Billion |
+0.01pp |
| 2020-12-31 | 0.00% | CN¥357.60K ≈ $52.33K |
CN¥20.86 Billion ≈ $3.05 Billion |
-1.14pp |
| 2017-12-31 | 1.14% | CN¥246.00 Million ≈ $36.00 Million |
CN¥21.64 Billion ≈ $3.17 Billion |
-0.31pp |
| 2016-12-31 | 1.45% | CN¥300.00 Million ≈ $43.90 Million |
CN¥20.76 Billion ≈ $3.04 Billion |
-2.18pp |
| 2015-12-31 | 3.62% | CN¥695.00 Million ≈ $101.70 Million |
CN¥19.17 Billion ≈ $2.81 Billion |
+3.62pp |
| 2014-12-31 | 0.00% | CN¥225.50K ≈ $33.00K |
CN¥17.30 Billion ≈ $2.53 Billion |
0.00pp |
| 2009-12-31 | 0.00% | CN¥71.40K ≈ $10.45K |
CN¥5.20 Billion ≈ $760.73 Million |
-4.94pp |
| 2001-12-31 | 4.94% | CN¥64.12 Million ≈ $9.38 Million |
CN¥1.30 Billion ≈ $190.07 Million |
-2.93pp |
| 2000-12-31 | 7.86% | CN¥94.90 Million ≈ $13.89 Million |
CN¥1.21 Billion ≈ $176.61 Million |
-- |
About Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small mol… Read more